排序方式: 共有16条查询结果,搜索用时 15 毫秒
1.
2.
3.
This study looked into a family involving a rare mother-child ABO blood type inconsistency and explored its genetic and molecular basis. In the family, the mother had type AB blood and the father was blood type B and they gave birth to a baby of blood type O. Their blood types were phenotypically identified by using different techniques, including micro-column gel test, immune inhibition test, absorption and elution tests. The sequences of all 7 exons of ABO allele from the core family members were determined by using PCR and clone-based sequencing. The loci of mutated gene were compared against normal human genes. The result showed that the mother’s erythrocytes were agglutinable with monoclonal anti-A antibody(2+) and had agglutination reaction with anti-B antibody(4+). The mother’s serum registered agglutination action with standard blood type A cells. The findings showed an ABO inconsistency. When domestic antibodies were used, the mother’s erythrocytes yielded agglutination reaction with humanized anti-B serum(4+) and anti-B monoclonal antibody but were non-agglutinable with humanized anti-A serum and anti-A monoclonal antibody. Upon absorption and elution, the titer of anit-A antibody was 128 both before and after the absorption test, with no significant difference found between pre- and post-absorption values. Our results confirmed that the mother’s allelic gene was type B and contained type A. The father’s blood type was type B, and son’s blood type was type O. Clone-based sequencing revealed that the mother carried a heterozygous gene of B101.01(nt A640→G)/O01, which contained an M214→V mutation that could express a weak expression of antigen A, resulting in blood type AB. However, their son did not have the M214→V mutation, which yielded a false ABO-inconsistency between him and his mother. We were led to conclude that type B gene with a M214→V mutation can encode both antigen B and weak antigen B that can lead to false ABO-inconsistencies. 相似文献
4.
目的:了解我院ICU患者铜绿假单胞菌的耐药性,为临床合理使用抗生素提供依据和探讨该耐药菌的防治方法。方法:临床分离的106株铜绿假单胞菌用法国梅里埃公司的VITEK-2全自动微生物分析系统鉴定,纸片扩散法进行抗生素敏感试验,采用纸片协同法检测金属酶表型,PCR法扩增金属酶基因。结果:2007~2009年共分离出106株铜绿假单胞菌,对头孢他啶、亚胺培南、哌拉西林、氨曲南、头孢哌酮、头孢吡肟、左氧氟沙星的耐药率分别为50.9%、39.6%、79.2%、56.6%、57.5%、41.5%、25.5%。结论:携带AmpC金属酶基因是本院ICU患者铜绿假单胞菌耐碳青霉烯类等多种药物的主要原因。 相似文献
5.
目的探讨Frenkel训练法对脑卒中本体感觉障碍患者功能恢复的影响。方法共选取有本体感觉功能障碍的脑卒中患者60例,将其随机分为治疗组和观察组,两组患者均采用常规康复措施进行训练,治疗组同时接受Frenkel训练法。康复评定采用Fugl-Meyer运动功能和四肢本体感觉功能评分法,患者日常生活活动能力(ADL)评定采用改良Barthel指数(MBI)。结果两组患者分别经训练后,其Fugl-Meyer运动功能评分和MBI评分均较治疗前明显改善(P〈0.01),但治疗组的效果优于对照组(P〈0.01)。结论本体感觉障碍能明显影响脑卒中患者康复疗效,脑卒中感觉障碍患者应用Frenkel训练法,不仅有利于其感觉功能进一步康复,而且对提高患者运动功能和ADL也有显著促进作用。 相似文献
6.
7.
8.
目的:分析血标本在不同放置时间和温度对血清乳酸脱氢酶(LD)的影响。方法:采用34例健康成人血标本分别放置于4℃~6℃、23℃~25℃和37℃,在即时、8 h、24 h、48 h、72 h和96 h测定其血清LD活性并进行分析比较。结果:在4℃~6℃条件下,分别于即时和放置8 h、24 h、48 h、72 h及96 h测定血清LD活性结果为(127.2±8.7)U/L、(125.5±12.6)U/L、(130.2±14.2)U/L、(145.8±18.4)U/L、(161.3±24.7)U/L和(191.2±28.0)U/L.经统计学分析,标本放置8 h和24 h与即时测定结果无明显差异(P>0.05),当标本放置48 h、72 h和96 h血清LD活性比即时测定结果明显升高(P<0.05、P<0.001);当标本放置24 h,冷藏组(4℃~6℃)、室温组(23℃~25℃)和温育组(37℃)血标本LD活性分别为(130.2±14.2)U/L、(141.9±15.1)U/L和(168.8±17.1)U/L,与即时测定结果比较,冷藏组(P>0.05)无明显差异,而室温组(P<0.05)和温育组(P<0.01)血清LD活性明显升高。结论:随着血标本放置时间的延长和放置温度的增加血清LD活性会逐渐升高。 相似文献
9.
口服灵芝保健品患者粪便用0.9%NaC l溶液涂片,在显微镜下观察灵芝孢子形态与肺吸虫卵形态,并对两者进行比较。结果粪便中灵芝孢子与肺吸虫卵形态上有很多相近之处,但两者还是各有特征。在实际工作中,粪便检查查到大量肺吸虫卵样物质时,应询问病史,结合临床,通过显微镜下形态学特征鉴别粪便中灵芝孢子与肺吸虫卵。 相似文献
10.
目的 通过构建临床输血智能化路径管理体系,分析实施后医疗机构临床用血趋势。方法 采用输血智能化路径管理系统与三级组织管理构架,实施临床输血全程闭环路径管理体系,实现输血质量数据的实时监控与统计分析。结果 1)成功构建科学、安全、规范的临床输血路径管理体系,能对输血过程中各节点执行情况进行记录,使临床输血全程质量及安全得到实时控制及质量持续改进。2)应用数据显示,与2012年相比,我院2016年在出院人次及手术人次均大幅度增加的情况下,总输血量控制良好;出院人均总用血量、手术人均总用血量、出院患者人均红细胞用量等指标均呈持续下降趋势(P0.01)。结论 临床输血智能化路径管理下我院用血量呈现逐年下降趋势,临床输血智能化路径管理系统对提升血液质量和科学安全有效用血水平等方面有良好的应用价值,同时为临床输血规范化管理和输血数据的区域性汇总、分析提供解决方案。 相似文献